Targeting the epidermal growth factor receptor (HER) family by T cell receptor gene-modified T lymphocytes
✍ Scribed by Peter Meyerhuber; Heinke Conrad; Lilian Stärck; Matthias Leisegang; Dirk H. Busch; Wolfgang Uckert; Helga Bernhard
- Book ID
- 105797005
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 482 KB
- Volume
- 88
- Category
- Article
- ISSN
- 0946-2716
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Genetic engineering of human T lymphocytes to express tumor antigen-specific chimeric immune receptors is an attractive means for providing large numbers of effector cells for adoptive immunotherapy while bypassing major mechanisms of tumor escape from immune recognition. We have applied this strate
Incubation of Swiss mouse 3T3 cells at 37°C with bovine brain-derived growth factor (BDGF) decreased the cell surface '251-EGF binding activity of these cells by 70-80%. This down-modulation of the EGF receptor by BDGF was time, temperature, and dose dependent. Scatchard plot analysis indicated that
## Abstract ## Background Despite improvements in the treatment of osteosarcoma (OS) there are still too many patients who cannot benefit from current treatment modalities. Therefore, new therapeutic approaches are warranted. Here we explore the efficacy of targeted adenoviral based suicide gene t
The epidermal growth factor receptor (EGFR) plays a critical role in normal growth and its overexpression is associated with several types of cancer. To learn more about regulation of the expression of this important receptor, we investigated the role of the TAF II 250 subunit of transcription facto